Sign in with Google. Opens in new tab
ENTITY
SMARTSCORE: 3.6/5
Grifols

Grifols (GRFS US)

30
Analysis
Health CareSpain
Grifols S.A. develops, manufactures, and markets plasma derivatives, IV Therapy, enteral nutrition, diagnostic systems, and medical materials.
more
bullishHenkel & KGaA
17 Sep 2024 15:58

Liquid Universe of European Ordinary and Preferred Shares: September‘24 Report

Since mid-August, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (13 have...

Share
bullishGrifols SA
30 Aug 2024 13:15

Brookfield Explores Sovereign Funds for Grifols Takeover Bid

Press reports Brookfield is seeking support from sovereign wealth funds, including those from Abu Dhabi (ADQ) and Singapore (GIC), to back its bid,...

Share
bullishGrifols SA
22 Aug 2024 21:45

Brookfield/Grifols: Update & Recap, Spread, Discount

Bloomberg reported that Brookfield (BN CN) is seeking bank backing for up to €9.5 billion in debt to facilitate a potential take-private...

Share
bullishGrifols
19 Aug 2024 09:48

Liquid Universe of European Ordinary and Preferred Shares: August‘24 Report

Since mid-July, share-price spreads have generally widened across our European liquid universe of ordinary and preferred shares (9 have tightened,...

Share
bullishGrifols
18 Jul 2024 11:44

Liquid Universe of European Ordinary and Preferred Shares: July‘24 Report

Since mid-June, share-price spreads have generally tightened across our European liquid universe of ordinary and preferred shares (13 have...

Share
x